Amplimune

This page contains information on Amplimune for veterinary use.
The information provided typically includes the following:

Amplimune Indications
Warnings and cautions for Amplimune
Direction and dosage information for Amplimune

Amplimune

This treatment applies to the following species:

Company: NovaVive USA

MYCOBACTERIUM CELL WALL FRACTION IMMUNOSTIMULANT

Amplimune Indications

For use in calves 1 to 5 days of age, as a one-time immunotherapeutic treatment for reduction of mortality and clinical signs associated with calf scours caused by E. coli K99.

DOSAGE: Aseptically administer 1 mL intravenously.

PRECAUTION: Store at 2°C-7°C (35°F-45°F). Do not freeze. Use entire contents when first opened. Contains gentamicin as a preservative. Do not administer within 21 days of slaughter. In case of anaphylaxis, administer epinephrine.

Patent Protected U.S. 4744984, 5632995, 5759554, 6139844, 6890541

For Veterinary Use Only

NovaVive USA Inc., Athens, GA 30601

U.S. Vet. Lic. No. 289

1-844-663-3349

5 mL (5 doses), 20 mL (20 doses), 100 mL (100 Doses)

CPN: 1843000.0

NOVAVIVE USA INC.
119 ROWE RD., ATHENS, GA, 30601

Toll-Free:		1-844-663-3349
Website:		www.novavive.ca
Email:		info@novavive.ca

THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.